503B Outsourcing Facility GMP & Compliance Support
Pharmaceutical-grade compliance expectations, often without a pharmaceutical-sized team behind them. We build systems that fit the facility you actually run.
Request a consultation
Discuss 503B compliance support.
125+ years of combined GMP experience. 89 clients supported.
The first call is discovery, no confidential details needed. We sign a CDA before any detailed review.
GMP, Quality and Compliance Support for 503B Outsourcing Facilities
503B outsourcing facilities operate under a compliance standard that looks a great deal like traditional pharmaceutical manufacturing, without always having the infrastructure or headcount of a large manufacturer behind them. Under Section 503B of the FD&C Act, outsourcing facilities must comply with current Good Manufacturing Practice requirements, and until FDA finalizes outsourcing-facility-specific CGMP regulations that means meeting the same 21 CFR Parts 210 and 211 requirements traditional manufacturers do, evaluated against the agency’s risk-based inspection approach for outsourcing facilities.
Amicus works with 503B outsourcing facilities to build quality systems, documentation and validation programs that hold up under that scrutiny, whether you are a newly registered facility or an established operation preparing for your next inspection.
Jamie Duncan, CQAPrincipal, QualityJamie brings nearly a decade of experience in pharmaceutical quality, compliance and operations within highly regulated environments. She holds ASQ Certified Quality Auditor and Certified Manager of Quality/Organizational Excellence certifications, plus a Lean Six Sigma Green Belt.
- Quality system development and optimization
- Internal audits and compliance readiness
- Process improvement and operational excellence
Becca Mitchell, PharmDPrincipal, Quality & Regulatory
Kristopher Le, PharmDCEO & FounderHow We Support 503B Outsourcing Facilities
GMP Consulting Services
We assess your current operations against CGMP expectations and FDA’s risk-based framework for outsourcing facilities, then build a prioritized, resourced plan to close compliance gaps without disrupting production.
FDA Compliance Support
From quality control unit oversight to lot release and complaint investigations, we help you establish the procedures and documentation FDA expects to see functioning as a system, not simply existing on paper.
Quality System and Documentation Support
We build and refine the SOPs, batch records and change control processes that support consistent production of drug products meeting your quality standards, with the traceability investigators look for.
Validation and Qualification Services
Our team supports validation of aseptic processing and terminal sterilization methods, equipment qualification and process validation, so your facility can demonstrate that its critical processes are controlled and repeatable.
Inspection Readiness and Audit Support
We prepare 503B facilities for FDA’s risk-based inspection schedule with full mock FDA-style inspections, documentation review, and front room and back room readiness support tailored to outsourcing facility operations. Amicus can also be on-site or on standby during a live inspection.
Common 503B Compliance Challenges We Help Solve
Gaps in Quality Systems and SOPs
Many outsourcing facilities scale production faster than their quality systems can keep pace, leaving SOPs outdated or inconsistently followed. We help close that gap before it becomes a finding.
Documentation and Batch Record Issues
Incomplete or inconsistent batch records are a leading source of FDA observations for outsourcing facilities. We review and strengthen your documentation practices so records tell a complete, accurate story.
Validation and Environmental Control Risks
Sterile and non-sterile compounding both carry contamination and mix-up risks that FDA evaluates closely. We help you build environmental monitoring, personnel monitoring and facility controls that manage that risk proactively.
Readiness for FDA Inspections
Because 503B facilities are inspected on a risk-based schedule, readiness cannot be a once-a-year exercise. We help you build ongoing inspection preparedness into daily operations.
Why 503B Outsourcing Facilities Choose Amicus
Outsourcing facilities operate in a uniquely demanding niche: pharmaceutical-grade compliance expectations, often with the resources of a much smaller organization. Amicus understands that balance. We do not hand you a generic pharmaceutical compliance template. We build solutions scaled to your facility’s volume, risk profile and growth plans, then stay engaged to help you implement them. A principal leads the work and reviews every deliverable, backed by 125+ years of combined experience across 89 clients.
What Our Clients Say
Our mock FDA audit with Amicus was incredibly helpful. They clearly explained where we had gaps, prioritized the issues, and offered practical ideas for fixing them. It gave our team much more confidence going into future inspections.
Director of Quality503B Outsourcing Facility
Working with Amicus on a mock FDA audit was a great experience. Their team was thorough, professional, and easy to work with, and they provided clear feedback that helped us better understand regulatory expectations.
Pharmacist in Charge503B Outsourcing Facility
Frequently Asked Questions
A registered outsourcing facility must comply with CGMP and may produce without patient-specific prescriptions, which places it much closer to a pharmaceutical manufacturer than to a compounding pharmacy. The documentation, validation and quality system expectations are correspondingly higher.
Before the systems are built rather than after. Retrofitting a quality system around an operating facility costs considerably more than designing it alongside.
Yes. Both carry contamination and mix-up risk that FDA examines closely, and both need environmental and personnel monitoring programs that stand up to review.
Yes, including a full mock FDA-style inspection run at the pace of a real one, and live support on-site or on standby during the inspection itself.
Yes. The first call is a discovery conversation and no confidential details are needed for it. We sign a CDA before any detailed review.
Related Industry and Service Pages
FDA Inspection Readiness Consulting
Mock inspections, gap assessments and live inspection support.
FDA 483 & Warning Letter Response
Risk-ranked remediation when observations have already been issued.
Regulatory Compliance Consulting
Strategy, gap assessments and documentation support across FDA requirements.
Speak With a 503B Compliance Consultant
Whether you are preparing for your first FDA inspection or strengthening an existing quality system, Amicus can help your outsourcing facility build compliance that scales with your growth.